Defining Our Cancer Moonshot
July 2, 2016
In what evolved into a cancer moonshot think tank, a special event was held at Weill Cornell Medicine on June 29, one of 270 held in tandem across the United States convened by Vice President Joe Biden, with a national summit at Howard University in Washington, DC.
Sequencing Reveals Molecular Underpinnings of Aggressive Prostate Cancer Subtype
February 9, 2016
A subset of treatment-resistant prostate cancer pathologically resembles small cell lung cancer rather than typical prostate cancer, Weill Cornell Medicine and University of Trento investigators discovered in a new study. The scientists say their findings may lead to more effective ways to diagnose and treat neuroendocrine prostate cancer.
New 3D goggles help doctors search for mutations in cancerous tumors
January 27, 2016
Researchers in New York are now using virtual reality to delve deep inside the human body in hopes of unlocking a cure for cancer.
Researchers at Weill Cornell Medicine developed the genome sequencing software application.
Doctors wear a virtual reality headset to visualize protein structures in 3D space, searching for mutations in tumors.
Tailored Cancer Treatments Fit Doctors’ New Approach
January 20, 2016
Scientists say we’re in a medical renaissance of sorts where the goal of curing cancer – the many different versions of it – may actually be in reach. NY1’s Erin Billups has more in part two of her look at precision medicine.
Gene Sequencing Effort Helps Pinpoint Cancer Treatments
January 16, 2016
In his State of the Union address President Barack Obama made finding a cure for cancer a moonshot of his final year in office. It’s a lofty goal as cancer is not just one disease but many. But with the help of doctors at a New York institute one woman may have found her cure, tailored just for her. NY1’s Erin Billups filed the following report.
New Treatment Options for Advanced-Stage Cancer Patients Revealed Through Next-Generation Sequencing Test
November 16, 2015
A powerful new test that can reveal untapped therapies for patients with advanced cancers by scanning thousands of their genes will soon be available for patients at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center. The test, EXaCT-1, identifies alterations within tumors — some of which drive cancerous growth — on a magnitude up to hundreds of times greater than similar technologies designed to pinpoint the most precise ways of treating the disease.
Gift Names Caryl and Israel Englander Institute for Precision Medicine
October 10, 2015
A significant investment in Weill Cornell’s leading precision medicine program by Overseer Israel Englander and his wife Caryl will expand the scope of the institution’s approach to understanding and treating disease through therapies customized to patients’ unique genetic profiles.
Precision Medicine: Working Toward Custom-Fitted Cures
May 8, 2015
The use of genetic data could fundamentally change how we treat disease.
Precision medicine can offer more tailored treatment options for patients.
This year may just be the year of precision medicine – a term that’s buzzing on health blogs and in research journals. Precision techniques, proponents say, could change the face of medicine forever.
The White House’s Precision Medicine Initiative
February 10, 2015
On January 30, 2015, President Obama unveiled the details of the Administration’s Precision Medicine Initiative, a bold new research effort to revolutionize the ways in which we improve health and treat disease. (Watch here). Dr. Mark A. Rubin, Director of the Institute for Precision Medicine, was in attendance at this by invitation only event.